This is where you will find financial information about Promore Pharma. You can download annual reports, quarterly reports and presentations and subscribe to our press releases and reports.
It is our ambition to provide the capital market, investors, shareholders and other stakeholders with relevant information to facilitate a fair valuation of the company and our external contacts. We strive to be as transparent as possible in all our actions. Do not hesitate to contact us if you require additional information.
- Promore Pharma starts trading on Nasdaq First North on 6 July 2017
- Promore Pharma awaiting approval from Nasdaq First North in next week
- New share issue in Promore Pharma raises 76 MSEK ahead of listing on Nasdaq First North
- Promore Pharma Carries Out a Share Issue Prior to Listing on Nasdaq First North